All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2016-N-3118
Mallinckrodt Pharmaceuticals; Proposal to Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets
Documents
449
Comments
0
Key Dates
Comment Period OpensOct 18, 2016
Comment Period ClosesDec 20, 2016
Documents
| Type | Title | Status |
|---|---|---|
Other |
Keywords
Mallinckrodt Pharmaceuticals
Abbreviated New Drug Application
xtended-Release Methylphenidate Tablets
2016-130
Data from Regulations.gov